NEWSROOM

Healthcare

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

Sep 16, 2025

Showcases SSi Mantra’s strengths in robotic telesurgery and opportunity in pediatrics Fort Lauderdale, FL – September 16, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world’s first pediatric pyeloplasty...

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

Sep 11, 2025

LAS VEGAS, Sept. 11, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the receipt of an initial purchase order from Noventis Medical, its exclusive Central America distribution partner, for the supply of 2,500 MyCardia AT Cardiac Event Monitoring devices. The total order value is...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit

Sep 9, 2025

Marks another milestone in the Company’s mission to bring advanced surgical robotic care to underserved patient populations Fort Lauderdale, FL, September 9, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - SS Innovations International, Inc.(the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

Sep 5, 2025

Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem’s proprietary allograft portfolio POMPANO BEACH, Fla., Sept. 05, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for...

Aclarion Appoints Greg Gould as Chief Financial Officer

Aclarion Appoints Greg Gould as Chief Financial Officer

Sep 3, 2025

HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $500M revenue while ensuring compliance and strengthening financial integrity Broomfield, CO, September 3, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies to Present at Two Upcoming Investor Conferences

Sep 2, 2025

POMPANO BEACH, Fla., Sept. 02, 2025 - PRISM MediaWire - Press Release Service - Press Release Distribution - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that Company management will present at the following upcoming investor conferences being held in New York, NY. Morgan Stanley Global Healthcare Conference: Format: Fireside Chat Date:...

IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics

IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics

Aug 25, 2025

BOSTON, August 25, 2025 - PRISM MediaWire - The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: IMDX), in an episode on “Democratizing Molecular Diagnostics: Transforming Transplant Success.” Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) In the episode, James discussed iMDx’s mission, the company’s focus on transplant diagnostics, and its strategy to...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

Aug 21, 2025

POMPANO BEACH, FL, August 21, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, discloses an insider purchase of common stock from Jason Matuszewski, Chairman and Chief Executive Officer of BioStem Technologies. Mr. Matuszewski purchased a total of 15,500 shares on August 19, 2025, totaling approximately $100,000. The purchases were...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results

Aug 14, 2025

POMPANO BEACH, FL, August 14, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today reported preliminary financial results for the second quarter ended June 30, 2025. Recent Business Highlights: Appointed Brandon Poe as Chief Financial Officer, a seasoned financial executive with experience across the...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies Appoints Brandon Poe as Chief Financial Officer

Aug 14, 2025

Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem’s financial team POMPANO BEACH, FL, August 14, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Brandon Poe as its Chief...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Reports Second Quarter 2025 Financial Results

Aug 7, 2025

Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth Fort Lauderdale, FL. August 7, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited...

American Shared Hospital Services Announces Second Quarter Financial Results Conference Call

American Shared Hospital Services Announces Second Quarter Financial Results Conference Call

Aug 6, 2025

Call Scheduled for August 13th at 1:00 PM ET SAN FRANCISCO, August 6, 2025 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced that the Company will hold a conference call to discuss its second quarter 2025 financial results on August 13th at 1:00 pm ET. The...

Aclarion Appoints Greg Gould as Chief Financial Officer

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

Aug 5, 2025

Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first time and expects continued QOQ growth for the remainder of the year Cost-effectiveness analysis demonstrating Nociscan is more effective and less costly than provocative discography published in peer-reviewed journal adding critical evidence in support of payer coverage Pivotal...

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Jul 30, 2025

NEW YORK, NY and SANTA BARBARA, CA, July 30, 2025 - PRISM MediaWire - Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March 31, 2041. This patent underpins one of the Company’s key pipeline assets, a modified stilbenoid, and importantly provides the Company with exclusivity to particular compounds per se, formulations containing a number of drug candidates, and...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025

Jul 30, 2025

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., July 29, 2025 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived products for advanced wound care, announces it will release its second quarter 2025 financial results on Thursday, August 14, 2025, and host a conference call and webcast at 4:30 PM ET. The webcast will feature a review of second quarter...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery

Jul 22, 2025

Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL, July 22, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

Jul 15, 2025

Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL, July 15, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries. To...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET

Jul 10, 2025

Jason Matuszewski, Chairman and CEO, to present BioStem’s current position in the chronic wound care market and key opportunities for growth POMPANO BEACH, Fla., July 10, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that Jason Matuszewski, the Company’s Chairman and CEO, will present at the Advanced Wound Care...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System

Jul 10, 2025

Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric & Robotic Surgery Centre in Indore, India. Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system. Fort...

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Jul 7, 2025

Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time Broomfield, CO, July 7, 2025 - PRISM MediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced that its Annual Meeting of Stockholders (the “Annual Meeting”) scheduled for July 7, 2025 has...

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

Jun 25, 2025

The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) Company reaffirms internal interim results of CLARITY...

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Jun 24, 2025

Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think Tank BROOMFIELD, Colo., June 24, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the upcoming State of...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers

Jun 23, 2025

Head-to-head study comparing BioREtain®- processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis expected in Q4 2025 POMPANO BEACH, Fla., June 23, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today...

BioStem Technologies (OTC: BSEM) Showcasing its Leading BioREtain®Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

Jun 17, 2025

Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies POMPANO BEACH, Fla., June 17, 2025 - PRISM MediaWire - Ernst & Young LLP (EY US) announced that Jason Matuszewski, CEO and Chairman of the Board of BioStem Technologies (OTC: BSEM), was named an Entrepreneur Of The Year 2025 Florida Award winner. Entrepreneur Of The Year is the preeminent competitive awards program for entrepreneurs and leaders of high-growth companies. For 40 years, EY US...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System

Jun 16, 2025

Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador PR Audio: Fort Lauderdale, FL, June 16, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the first robotic cardiac surgery in the Americas and Western Hemisphere has been successfully performed...

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Jun 10, 2025

UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., June 10,...

Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision

Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision

Jun 4, 2025

Toronto, ON, June 4, 2025 - PRISM MediaWire - Ultrack Systems Inc. (OTC: MJLB), a fast-growing leader in smart logistics technologies, is thrilled to announce the acquisition of a 60% controlling interest in Better Pets, a rising star in the science-driven pet wellness industry. This strategic move catapults MJLB into the booming $325 billion global pet care market—one of the fastest-growing consumer sectors in the world. The transaction, comprised of a mix of cash and equity, also gives...

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Jun 4, 2025

Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral Lichen Planus, a condition with no approved treatments PITTSBURGH, June 4, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it has re-signed its manufacturing collaboration agreement with Cook...

BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process

BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process

Jun 3, 2025

Upon SEC approval of the amended Form 10, BioStem expects to advance its uplisting to Nasdaq POMPANO BEACH, Fla., June 3, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today provides an update on the Company’s Form 10 registration statement and SEC review process. BioStem believes it has favorably...

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System

SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025

Jun 2, 2025

Fort Lauderdale, FL, June 2, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company will ring the opening bell at the Nasdaq MarketSite in New York City on Tuesday, June 3, 2025. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS...